| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Imatinib Mesylate | FAERS: 5 | US FAERS | |
| 2 | Norgestrel | FAERS: 4 | OFFSIDES US FAERS | |
| 3 | rucaparib | FAERS: 2 | US FAERS | |
| 4 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 5 | Octreotide | FAERS: 1 | US FAERS | |
| 6 | Tacrolimus | FAERS: 1 | US FAERS | |
| 7 | liposomal doxorubicin | FAERS: 1 | US FAERS | |
| 8 | pazopanib | FAERS: 1 | US FAERS | |
| 9 | Biotin | OFFSIDES | ||
| 10 | Cimetidine | OFFSIDES | ||
| 11 | Ephedrine | OFFSIDES | ||
| 12 | Letrozole | OFFSIDES | ||
| 13 | Loratadine | OFFSIDES | ||
| 14 | Pyridoxine | OFFSIDES | ||
| 15 | Vitamin E | OFFSIDES | ||
| 16 | alfacalcidol | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.